Michael is joined by Dr Ross Walker, cardiologist & host of Nine Radio’s Healthy Living, for his appraisal of AstraZeneca in the COVID-19 vaccine debate.

This follows AstraZeneca’s chief executive Pascal Soriot recently suggesting that the durability of T-cells from the Oxford jab could be keeping older people safer than those on the European continent, hinting that its response is more durable than mRNA jabs such as Pfizer & Moderna.

Download this podcast here